Titlebook: Biologics for the Treatment of Rheumatoid Arthritis; Ronald F van Vollenhoven Book 2016 Springer International Publishing Switzerland 2016

fulcrum

BARGE

Cytokine inhibitors,as in the field of oncological research, where in the early 1980s it was established as the mediator of tumor-related cachexia (and because of this it was also named ‘cachectin’) and in separate lines of research it was shown to be capable of inducing necrosis of malignant cells in vitro, giving it

表皮

persistence

airborne

Strategies for the optimal use of biologic agents in rheumatoid arthritis,gment of the patient population had failed all available conventional agents and had ongoing moderate or severe inflammation with progressive destruction of the joints. Even though some conventional approaches using more aggressive combinations of disease-modifying antirheumatic agents (DMARDs) seem

BILL